OCT angiography could represent a novel and helpful early biomarker for diagnosing and monitoring multiple sclerosis progression, as shown in a study presented at the virtual Euretina congress.
“OCT-A parameters showed retinal vascular abnormalities before the appearance of subsequent neuroaxonal loss,” Daniela Montorio, MD, said.
In 30 eyes of 15 patients, changes in retinal and choriocapillary vessel density were evaluated on OCT-A over 2 years after an initial demyelinating event (IDE), the first neurological symptom of MS referrable to demyelination in the central nervous